Qualigen Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/14/2022 | 1.03 M | $274.00 K | 0.00% | 2.60% |
| BLACKROCK INC. | 11/14/2022 | 258.42 K | $69.00 K | 0.00% | 0.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 226.67 K | $60.00 K | 0.00% | 0.57% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2022 | 128.90 K | $35.00 K | 0.00% | 0.33% |
| STATE STREET CORP | 11/15/2022 | 109.31 K | $29.00 K | 0.00% | 0.28% |
| HIGHMARK WEALTH MANAGEMENT LLC | 10/21/2022 | 80.09 K | $21.00 K | 0.00% | 0.20% |
| UBS GROUP AG | 11/10/2022 | 56.78 K | $16.00 K | 866.25% | 0.14% |
| FRANKLIN RESOURCES INC | 11/14/2022 | 55.45 K | $15.00 K | 0.00% | 0.14% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/25/2022 | 48.64 K | $13.00 K | 0.00% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2022 | 47.96 K | $13.00 K | 36.91% | 0.12% |
| NORTHERN TRUST CORP | 11/14/2022 | 43.25 K | $12.00 K | 0.00% | 0.11% |
| WEDBUSH SECURITIES INC | 10/18/2022 | 32.23 K | $9.00 K | 0.00% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2022 | 22.90 K | $6.00 K | -62.46% | 0.06% |
| KESTRA ADVISORY SERVICES, LLC | 11/01/2022 | 20.00 K | $5.00 K | 0.00% | 0.05% |
| CRA FINANCIAL SERVICES, LLC | 10/24/2022 | 19.96 K | $5.00 K | 0.00% | 0.05% |
| BANK OF NEW YORK MELLON CORP | 11/14/2022 | 18.88 K | $5.00 K | 0.00% | 0.05% |
| GROUP ONE TRADING, L.P. | 11/09/2022 | 18.25 K | $5.00 K | 0.00% | 0.05% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2022 | 14.50 K | $4.00 K | 100.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/10/2022 | 13.25 K | $4.00 K | 43.66% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2022 | 12.10 K | $3.00 K | -71.93% | 0.03% |
| US BANCORP \DE\ | 10/27/2022 | 8.24 K | $2.00 K | 0.00% | 0.02% |
| RETIREMENT GROUP, LLC | 11/14/2022 | 3.50 K | $1.00 K | 100.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/04/2022 | 536 | $0 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 258 | $0 | 18.89% | 0.00% |
| GLASSMAN WEALTH SERVICES | 11/09/2022 | 200 | $0 | 0.00% | 0.00% |
| GUARDIAN WEALTH ADVISORS, LLC | 11/09/2022 | 200 | $0 | 100.00% | 0.00% |
| ARCHER INVESTMENT CORP | 11/09/2022 | 160 | $43 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2022 | 48 | $0 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2022 | 11 | $0 | 1,000.00% | 0.00% |
| IFP ADVISORS, INC | 11/08/2022 | 1 | $1.00 K | 0.00% | 0.00% |
| CREDIT SUISSE AG/ | 11/10/2022 | 1 | $0 | 0.00% | 0.00% |
| ATLAS CAPITAL ADVISORS LLC | 11/08/2022 | 1 | $0 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 11/15/2022 | 0 | $0 | 0.00% | 0.00% |
| CREATIVE PLANNING | 11/03/2022 | 0 | $0 | -100.00% | 0.00% |
| SOLTIS INVESTMENT ADVISORS LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 11/13/2023 | 0 | $0 | -100.00% | 0.00% |
Qualigen Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Qualigen Therapeutics, Inc.. The most heavily invested institutionals were:
HATTON CONSULTING, INC.: 27,195
QS Investors, LLC: 82,000
5.66% of Qualigen Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 109.20 K shares in the last 24 months. This purchase volume represents approximately $571.09 K in transactions.